Radar · Life Sciences in Paris
Best Life Sciences Companies in Paris, France
The 300 best Life Sciences companies in Paris, France in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Owkin.
By Riya SenguptaFinancials
300companies tracked
$4.8Bdisclosed funding
1unicorns
153have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × PARIS
Our analysis of 50 Life Sciences companies
$3.3b in tracked funding; 62% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
50companies analysed
62%cloud-native stacks
2025funding peak (by rounds)
1unicorns
2015median founding year
539kcombined LinkedIn audience
27%of audience held by top 3
4companies hiring publicly (12 mo)
Ranked: Best Life Sciences companies in Paris
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Owkin 🦄 AI generative biology company to create the new standard of biology reasoning 89AI top 18%Innovation top 21%Patents top 21%Funding top 23% All 12 signals ▾AItop 18% Innovationtop 21% Patentstop 21% Fundingtop 23% Growthtop 23% Moattop 25% Globaltop 34% Fin. healthtop 37% Talenttop 38% Markettop 40% Techtop 46% Newsbottom 27% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Innovation: 49 patents (top 29% of patent-holders) · 39 filings since 2022 vs 10 in 2017-21 rank vs industry peers · Fliar Intelligence Index 89/100 | $321M | 3 mo ago | 47 | Gilles Wainrib Co-Founder | WebflowApple iCloud MailGoogle Workspace+21 | 25 patents AI-powered medical imaging analysis for cancer prognosis and federated learning networks | 1 launch |
| 2 | Abivax Developer of therapeutics for chronic inflammatory diseases | $320M | 39 mo ago | 26 | — | DrupalPHPAmazon Web Services+32 | 616 patents Small-molecule heterocyclic therapeutics for RNA viruses and inflammatory diseases | 1 launch |
| 3 | DNA Script Developer of benchtop DNA printer for nucleic acid synthesis | $315M | 33 mo ago | 202 | Xavier Godron Co-founder & CTO | WordPress Block EditorWordPressBugHerd+30 | 334 patents Enzymatic, template‑free nucleic acid synthesis and purification for custom DNA manufacturing | — |
| 4 | Cellectis Developer of cancer immunotherapies based on gene-edited CAR T-cells 64Patents top 20%Funding top 25%Product top 29%Innovation top 30% All 11 signals ▾Patentstop 20% Fundingtop 25% Producttop 29% Innovationtop 30% Newstop 33% Markettop 38% Moattop 41% Globaltop 45% Growthtop 48% Talentbottom 49% Techbottom 46% Patents: 1,579 patents matched (strict assignee match) · 326 filings since 2022 vs 610 in 2017-21 Funding: Raised $267M across 3 rounds · 3 rounds over 12 yrs (0.2/yr) rank vs industry peers · Fliar Intelligence Index 64/100 | $267M | 25 mo ago | 236 | Andre Choulika Chief Executive Officer | ExpressionEngineApple iCloud MailMicrosoft 365+14 | 1,579 patents Patents concentrated in chemistry & materials | — |
| 5 | HiFiBiO Provider of a technology platform for the discovery of antibody-based drugs | $180M | 60 mo ago | 75 | Liang Schweizer Founder | — | 36 patents Ligand‑receptor pair identification and biosensor assay technologies for drug discovery | — |
| 6 | Syremis Developer of novel medicines for mental health conditions 22Funding top 20%Global top 45%Talent bottom 49%Tech bottom 29% All 5 signals ▾Fundingtop 20% Globaltop 45% Talentbottom 49% Techbottom 29% Marketbottom 25% Funding: Raised $165M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Global: Investors from 3 countries beyond France rank vs industry peers · Fliar Intelligence Index 22/100 | $165M | 6 mo ago | — | Elisabeth Kogan Co-Founder & CEO | WordPressMySQLPHP+15 | — | — |
| 7 | TISSIUM Developer of vascular sealant for open vascular surgery | $156M | 36 mo ago | 107 | Jeffrey Karp Co-Founder | WordPressPleskMySQL+18 | 112 patents Patents concentrated in health & consumer products | 1 award |
| 8 | Enterome Developer of immunomodulatory drugs targeting cancer and immune diseases | $130M | 71 mo ago | 70 | — | — | 188 patents Microbiome-derived antigenic peptides for cancer immunotherapy and B‑cell malignancy treatment | — |
| 9 | SparingVision Developer of drugs using gene therapy to treat retinitis pigmentosa | $128M | 45 mo ago | 41 | Jose Sahel Co-Founder | WordPress Block EditorwpBakeryWordPress+24 | 37 patents Ophthalmic gene/biologic therapies enhancing retinal neuron survival and light sensitivity | 2 awards |
| 10 | CorWave Developer of implantable blood pumps for the treatment of heart failure | $127M | 35 mo ago | 77 | — | WordPressMySQLPHP+11 | 88 patents Implantable ventricular assist devices and control systems for cardiac blood pumps | 1 award |
| 11 | Inotrem Developer of peptide immunotherapies for treating septic shock and acute myocardial infarction | $122M | 31 mo ago | 35 | Marc Derive Co-Founder and CSO | WordPressMySQLPHP+23 | 52 patents TREM-1 targeted diagnostics and therapeutics for inflammation, sepsis, and cardiovascular risk | — |
| 12 | BioSerenity Provider of smart healthcare solutions for sleep and EEG lab management 60Moat top 19%Tech top 25%Patents top 29%Innovation top 34% All 11 signals ▾Moattop 19% Techtop 25% Patentstop 29% Innovationtop 34% Fundingtop 34% Markettop 45% Growthtop 45% Producttop 46% Newsbottom 43% Globalbottom 42% Fin. healthbottom 36% Moat: Editorial + unicorn rating 8/10 · IP moat: 140 patents Tech: 53 technologies across 6/8 capability areas · Cloud: Amazon Alb, Amazon Cloudfront rank vs industry peers · Fliar Intelligence Index 60/100 | $121M | 31 mo ago | 340 | — | WordPressApple iCloud MailMicrosoft 365+24 | 140 patents Wearable EEG and physiological monitoring systems with textile and in-ear electrodes | — |
| 13 | Limflow Developer a system for venous arterialization of the lower limbs | $97M | 50 mo ago | 46 | — | WordPressMySQLPHP+17 | — | — |
| 14 | AFYREN Provider of analytical services for microbiology, chemistry and bioprocesses industries 40Funding top 25%Talent top 28%Moat top 35%Patents top 37% All 11 signals ▾Fundingtop 25% Talenttop 28% Moattop 35% Patentstop 37% Techtop 43% Innovationtop 48% Growthtop 48% Newsbottom 49% Globalbottom 40% Marketbottom 32% Fin. healthbottom 20% Funding: Raised $96.9M across 7 rounds · 7 rounds over 11 yrs (0.6/yr) Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 40/100 | $97M | 1 mo ago | 32 | Regis Nouaille Co-Founder | WordPress Site EditorWordPressMySQL+24 | 118 patents Recovery and valorization of potassium salts and metabolites from anaerobic fermentation processes | — |
| 15 | Vivet Therapeutics Developer of gene therapies for inherited metabolic diseases | $91M | 28 mo ago | 30 | Jean-Philippe Combal Co-Founder & Chief Executive Officer | WordPress Block EditorElementorWordPress+21 | 34 patents Gene‑therapy vectors and promoters for treating inherited cholestatic liver diseases | — |
| 16 | Corteria Pharmaceuticals Developer of therapeutics for the treatment of heart failure | $83M | 33 mo ago | 10 | Marie Ozoux Co-Founder | WordPressMySQLPHP+15 | 13 patents Therapeutic CRF2 receptor agonist compounds for stress‑related disorder treatment | — |
| 17 | AB Science Developer of tyrosine kinase inhibitors for multiple disease indications 42Funding top 20%Patents top 21%Innovation top 28%Moat top 28% All 9 signals ▾Fundingtop 20% Patentstop 21% Innovationtop 28% Moattop 28% Newstop 33% Growthtop 45% Techbottom 41% Globalbottom 38% Marketbottom 21% Funding: Raised $83.2M across 9 rounds · 9 rounds over 9 yrs (1.0/yr) Patents: 461 patents matched (strict assignee match) · 78 filings since 2022 vs 86 in 2017-21 rank vs industry peers · Fliar Intelligence Index 42/100 | $83M | 1 mo ago | 3 | — | WordPressPleskMySQL+22 | 461 patents Small-molecule kinase and tubulin inhibitors for oncology and rare disease therapies | — |
| 18 | GenSight Biologics Developer of viral vector-based gene therapies for retinal neurodegenerative diseases 55AI top 15%Product top 19%Funding top 20%Patents top 33% All 11 signals ▾AItop 15% Producttop 19% Fundingtop 20% Patentstop 33% Moattop 38% Innovationtop 43% Globaltop 47% Growthbottom 47% Marketbottom 41% Newsbottom 33% Techbottom 31% AI: Holds AI/ML patents (G06N-family CPC) Product: 3 distinct product lines · Company stage: Public rank vs industry peers · Fliar Intelligence Index 55/100 | $77M | 3 mo ago | 23 | — | WordPressMySQLPHP+12 | 89 patents Optogenetic retinal devices and AAV gene‑therapy vectors for vision restoration | 1 award |
| 19 | Wandercraft Provider of AI-powered exoskeleton solutions 74Innovation top 19%Patents top 22%Moat top 26%Talent top 28% All 13 signals ▾Innovationtop 19% Patentstop 22% Moattop 26% Talenttop 28% Fundingtop 31% Growthtop 35% Producttop 36% AItop 45% Markettop 46% Fin. healthbottom 46% Techbottom 45% Globalbottom 42% Newsbottom 18% Innovation: 132 patents (top 15% of patent-holders) · 78 filings since 2022 vs 41 in 2017-21 Patents: 132 patents matched (strict assignee match) · 78 filings since 2022 vs 41 in 2017-21 rank vs industry peers · Fliar Intelligence Index 74/100 | $67M | 12 mo ago | 117 | Alexandre Boulanger Co-Founder | Webflow EcommerceWebflowAxeptio+15 | 132 patents Powered lower-body exoskeletons with 3‑DOF hip joints and AI‑based gait stabilization | 2 partnerships |
| 20 | Aqemia Provider of an AI and quantum physics to discover therapeutic molecules 60Funding top 28%AI top 30%Moat top 38%Tech top 39% All 11 signals ▾Fundingtop 28% AItop 30% Moattop 38% Techtop 39% Innovationtop 44% Growthtop 48% Patentstop 49% Talentbottom 49% Marketbottom 44% Globalbottom 36% Newsbottom 18% Funding: Raised $62.7M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) AI: Classified as an AI company · Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 60/100 | $63M | 14 mo ago | 60 | Maximilien Levesque Founder & CEO | WebflowApple iCloud MailGoogle Workspace+15 | 4 patents Small-molecule inhibitors of METTL3 RNA methyltransferase and MAP4K1 kinase for therapeutic use | 1 job opening |
| 21 | Carthera Devices focused on the treatment of brain tumors | $55M | 30 mo ago | 20 | — | WordPressCart FunctionalityMySQL+16 | 96 patents Implantable acoustic lens devices for brain imaging and therapy | — |
| 22 | Eligo Bioscience Developer of in vivo gene editing technology for microbiome modulation 48Patents top 16%Innovation top 19%Moat top 29%Funding top 36% All 11 signals ▾Patentstop 16% Innovationtop 19% Moattop 29% Fundingtop 36% Techtop 48% Talentbottom 49% Growthbottom 48% Globalbottom 44% Marketbottom 42% Fin. healthbottom 27% Newsbottom 22% Patents: 199 patents matched (strict assignee match) · 142 filings since 2022 vs 57 in 2017-21 Innovation: 199 patents (top 13% of patent-holders) · 142 filings since 2022 vs 57 in 2017-21 rank vs industry peers · Fliar Intelligence Index 48/100 | $52M | 13 mo ago | 44 | Xavier Duportet Co-Founder & CEO | WordPressVisual ComposerwpBakery+26 | 199 patents Targeted phage-based therapies and diagnostics for Cutibacterium acnes skin disorders | 1 job opening |
| 23 | SafeHeal Developer of a medical device for colorectal surgery 45Funding top 27%Growth top 35%News top 36%Tech top 39% All 9 signals ▾Fundingtop 27% Growthtop 35% Newstop 36% Techtop 39% Moattop 39% Patentsbottom 47% Innovationbottom 44% Globalbottom 43% Marketbottom 30% Funding: Raised $52.0M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 45/100 | $52M | 9 mo ago | 16 | — | WordPressMySQLPHP+32 | 15 patents Intra‑operative intestinal anastomosis cleaning and protection devices | — |
| 24 | Egle Therapeutics Provider of T cells based therapeutics for oncology and autoimmune diseases 45Funding top 34%Talent top 38%Moat top 39%Patents top 40% All 7 signals ▾Fundingtop 34% Talenttop 38% Moattop 39% Patentstop 40% Innovationbottom 49% Marketbottom 44% Globalbottom 43% Funding: Raised $46.6M across 2 rounds · 2 rounds over 5 yrs (0.4/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 45/100 | $47M | 15 mo ago | 28 | Eliane Piaggio Co-Founder | — | 11 patents Engineered cytokine therapeutics and biomarkers for cancer immunotherapy | — |
| 25 | Coave Therapeutics Developer of gene therapy for ocular and neurological disease 50Funding top 33%Patents top 34%Growth top 35%Moat top 36% All 9 signals ▾Fundingtop 33% Patentstop 34% Growthtop 35% Moattop 36% Innovationtop 42% Talentbottom 49% Techbottom 44% Globalbottom 43% Marketbottom 38% Funding: Raised $44.0M across 6 rounds · 6 rounds over 12 yrs (0.5/yr) Patents: 27 patents matched (strict assignee match) · 26 filings since 2022 vs 1 in 2017-21 rank vs industry peers · Fliar Intelligence Index 50/100 | $44M | 17 mo ago | 34 | Rodolphe Clerval Chief Executive Officer | WordPressApple iCloud MailMicrosoft 365+23 | 27 patents Engineered AAV viral vectors with lactam/squaramide capsid modifications for CNS gene therapy | — |
| 26 | Ganymed Robotics Surgical robotic assistants for orthopedic surgeons | $38M | 41 mo ago | 40 | Sophie Cahen Founder & CEO | WixSentryBootstrap+12 | 77 patents Computer‑assisted orthopedic surgery: intra‑operative navigation, segmentation, and drill guidance. | — |
| 27 | May Health Provider of solution for restoring ovulation in PCOS patients 40Funding top 29%Moat top 29%Growth top 35%Tech top 47% All 7 signals ▾Fundingtop 29% Moattop 29% Growthtop 35% Techtop 47% Newstop 48% Globalbottom 36% Marketbottom 29% Funding: Raised $36.2M across 3 rounds · 3 rounds over 7 yrs (0.4/yr) Moat: Editorial + unicorn rating 7/10 · 1 curated direct competitors tracked rank vs industry peers · Fliar Intelligence Index 40/100 | $36M | 3 mo ago | 12 | — | WordPressMySQLPHP+20 | — | — |
| 28 | Inato AI-based patient recruitment platform | $36M | 38 mo ago | 49 | Philippe Ravaud Co-Founder | — | — | — |
| 29 | Bioptimus Developer of AI foundation model to transform biological research 64AI top 20%Talent top 23%Funding top 33%Growth top 35% All 9 signals ▾AItop 20% Talenttop 23% Fundingtop 33% Growthtop 35% Moattop 42% Techbottom 49% Globalbottom 38% Marketbottom 36% Newsbottom 18% AI: Classified as an AI company Talent: 6 named leaders on record · 6 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 64/100 | $35M | 17 mo ago | — | Jean-Philippe Vert Co-Founder | WebflowGSAPMicrosoft Advertising+16 | — | 2 launchs · 1 partnership |
| 30 | Mauna Kea Tech Endomicroscopy devices for Gastrointestinal and Respiratory tracts | $30M | 31 mo ago | 67 | — | WordPressApple iCloud MailGoogle Workspace+25 | — | — |
| 31 | Robeauté Developer of microrobots for neurosurgical applications 35Growth top 35%Talent top 38%Funding top 44%Global bottom 39% All 6 signals ▾Growthtop 35% Talenttop 38% Fundingtop 44% Globalbottom 39% Techbottom 38% Marketbottom 27% Growth: Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 35/100 | $28M | 17 mo ago | 15 | Joana Cartocci Co-Founder & COO | WebflowApple iCloud MailMicrosoft 365+8 | — | — |
| 32 | Chipiron Developer of portable MRI machines 29Moat top 39%Innovation top 40%Funding top 41%Patents top 41% All 10 signals ▾Moattop 39% Innovationtop 40% Fundingtop 41% Patentstop 41% Talentbottom 49% Growthbottom 47% Techbottom 40% Globalbottom 40% Marketbottom 20% Newsbottom 17% Moat: Editorial + unicorn rating 3/10 · IP moat: 22 patents Innovation: 22 patents (top 71% of patent-holders) · 22 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 29/100 | $21M | 13 mo ago | 7 | Evan Kervella Co-founder & CEO | RubyAnimate.cssVarnish+12 | 22 patents Patents concentrated in computing, sensing & instrumentation | — |
| 33 | SquareMind Developer of robotic medical equipment for skin cancer detection 50AI top 15%Patents top 28%Innovation top 32%Moat top 32% All 9 signals ▾AItop 15% Patentstop 28% Innovationtop 32% Moattop 32% Fundingtop 38% Talentbottom 49% Globalbottom 43% Techbottom 41% Marketbottom 26% AI: Holds AI/ML patents (G06N-family CPC) Patents: 57 patents matched (strict assignee match) · 48 filings since 2022 vs 9 in 2017-21 rank vs industry peers · Fliar Intelligence Index 50/100 | $21M | 1 mo ago | 10 | Ali Khachlouf Co-Founder & CEO | PrismicNode.jsVue.js+7 | 57 patents Robotic arm guidance systems and AI-driven medical imaging marker generation | — |
| 34 | EG 427 Developer of gene therapies for neurogenic bladder 35Talent top 28%Patents top 37%Funding top 38%Moat top 39% All 9 signals ▾Talenttop 28% Patentstop 37% Fundingtop 38% Moattop 39% Innovationtop 48% Globalbottom 43% Marketbottom 33% Techbottom 33% Newsbottom 20% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Patents: 17 patents matched (strict assignee match) · 17 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 35/100 | $20M | 15 mo ago | 17 | Pierre Denys Co-Founder | PleskPHPYouTube+11 | 17 patents HSV‑1 based viral gene‑therapy vectors for neurological and bladder disease treatments | — |
| 35 | Gradient Denervation Technologies Provider of an endovascular, catheter-based technology to treat pulmonary hypertension | $19M | 33 mo ago | 4 | Martin Grasse CEO | — | 18 patents Energy-based pulmonary artery and cardiac sympathetic denervation devices | — |
| 36 | Astraveus Provider of a device for autologous cell and gene therapies | $18M | 17 mo ago | 29 | Jeremie Laurent Founder & CEO | WordPressMySQLPHP+25 | 51 patents Parallel microfluidic bioprocessing platforms for high‑throughput cell and particle handling | — |
| 37 | DeepLife Provider of AI-based drug discovery and omics analysis tool for researchers 37AI top 22%Funding top 40%Moat top 45%Patents top 48% All 8 signals ▾AItop 22% Fundingtop 40% Moattop 45% Patentstop 48% Innovationtop 49% Talentbottom 49% Globalbottom 39% Marketbottom 24% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Funding: Raised $16.4M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 37/100 | $16M | 18 mo ago | 10 | Jonathan Baptista Co-Founder & CEO | — | 4 patents Patents concentrated in computing, sensing & instrumentation | 1 award |
| 38 | Affluent Medical Developer of minimally invasive prostheses for structural heart disease, vascular therapy, and urology | $12M | 28 mo ago | 52 | Sebastien Ladet CEO | WordPressUnbounceDivi+17 | — | — |
| 39 | Nanobiotix Developer of nanotherapeutics designed to enhance cancer treatment via radioenhancement | $11M | 30 mo ago | 102 | — | DrupalApple iCloud MailMicrosoft 365+24 | 478 patents Patents concentrated in health & consumer products | 1 partnership |
| 40 | Spore Biotechnologies Developer of microbial detection technology for life science industries 53AI top 15%Growth top 35%Talent top 38%Funding top 42% All 10 signals ▾AItop 15% Growthtop 35% Talenttop 38% Fundingtop 42% Moattop 42% Techtop 43% Patentstop 46% Innovationbottom 47% Globalbottom 39% Marketbottom 23% AI: Holds AI/ML patents (G06N-family CPC) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $9M | 5 mo ago | 5 | Amine Raji Co-Founder & CEO | RubyAnimate.cssTailwind CSS+12 | 7 patents Rapid bacterial detection and analysis using spectroscopic and AI-driven diagnostic devices | 1 job opening · 1 award |
| 41 | Kyron.bio Developer of bioproduction platform for drug discovery and development 27Growth top 35%Funding top 45%Talent bottom 49%Tech bottom 45% All 6 signals ▾Growthtop 35% Fundingtop 45% Talentbottom 49% Techbottom 45% Globalbottom 36% Marketbottom 17% Growth: Fresh capital in last 24 mo Funding: Raised $7.7M across 4 rounds · 4 rounds over 3 yrs (1.3/yr) rank vs industry peers · Fliar Intelligence Index 27/100 | $8M | 12 mo ago | 6 | Emilia McLaughlin Founder | WixSentryBootstrap+10 | — | — |
| 42 | HEPTA Medical Developer of minimally invasive non-surgical treatment for cancer | $6M | 21 mo ago | 7 | Thomas Bancel CEO | — | — | — |
| 43 | Biomemory Online platform offering bio-digital data storage solutions | $5M | 18 mo ago | 10 | Erfane Arwani Co-Founder & CEO | WebflowGSAPLenis+15 | — | — |
| 44 | One Biosciences Developer of single-cell therapeutics solutions to treat multiple health disorders | $5M | 11 mo ago | — | Celine Vallot Co-Founder | WordPressMySQLPHP+7 | — | 1 partnership · 1 expansion · 2 awards |
| 45 | Lifeaz Developer of connected defibrillators 55Growth top 28%Talent top 28%Tech top 32%Funding top 41% All 10 signals ▾Growthtop 28% Talenttop 28% Techtop 32% Fundingtop 41% Producttop 46% Moattop 47% Marketbottom 47% Patentsbottom 35% Innovationbottom 32% Globalbottom 31% Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo Talent: 4 named leaders on record · 4 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 55/100 | $5M | 4 mo ago | 52 | Martial Itty Co-Founder & CTO | Webflow EcommerceCart FunctionalityWebflow+28 | 5 patents Portable cardiac defibrillation kits and integrated measurement systems for emergency care | — |
| 46 | Brink Therapeutics Developer of cell and gene therapies to treat various diseases | $4M | 14 mo ago | — | Jonathan Naccache Co-Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+12 | — | — |
| 47 | Primaa Provider of AI-based software for detection of cancer 40AI top 35%Talent top 38%Funding top 42%Moat top 48% All 7 signals ▾AItop 35% Talenttop 38% Fundingtop 42% Moattop 48% Techbottom 38% Globalbottom 37% Marketbottom 35% AI: Product described with: ai-based, artificial intelligence Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 40/100 | $2M | 7 mo ago | 35 | Stephane Sockeel Chief Scientific Officer and Co-Founder | WordPressMySQLPHP+19 | — | 1 partnership · 2 awards |
| 48 | Abbelight Provider of solutions for microscopes, reagents, and software for image analysis 57AI top 15%Product top 30%Moat top 32%Innovation top 40% All 9 signals ▾AItop 15% Producttop 30% Moattop 32% Innovationtop 40% Patentstop 40% Fundingtop 42% Techbottom 48% Marketbottom 42% Globalbottom 36% AI: Holds AI/ML patents (G06N-family CPC) Product: 4 distinct product lines · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 57/100 | $2M | 5 mo ago | 42 | — | WordPressMySQLPHP+19 | 24 patents Super-resolution single-molecule fluorescence microscopy hardware and image data handling | 2 awards |
| 49 | EVerZom Developer of a technology platform for the production of extracellular vesicles | $1M | 12 mo ago | 17 | Max Piffoux Co-Founder & CTO | WordPress Block EditorWordPressMySQL+18 | — | — |
| 50 | InBrain Pharma Developer of therapeutic solutions for the treatment of neurodegenerative diseases | $1M | 13 mo ago | 4 | Matthieu Fisichella Co-Founder & CEO | — | — | — |
Top 12 Life Sciences companies in Paris
#1
Owkin 🦄Series B · Paris, Ile de France · founded 2016 · 47 employees$321.1Mraised▾
Owkin 🦄
Series B · Paris, Ile de France · founded 2016 · 47 employees
AI generative biology company to create the new standard of biology reasoning. The company is creating the only large-scale reasoning model trained natively on patient-level multimodal data and reinforced through real biological feedback — a closed-loop system that continuously improves itself. It is building the operating system for biology a platform in general-purpose biology intelligence.
Fliar Intelligence Index™ 89how this company ranks against its industry peers
AI
top 18%Innovation
top 21%Patents
top 21%Funding
top 23%Growth
top 23%Moat
top 25%AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC)
Innovation: 49 patents (top 29% of patent-holders) · 39 filings since 2022 vs 10 in 2017-21 · Deep-tech classification: Artificial Intelligence
Patents: 49 patents matched (strict assignee match) · 39 filings since 2022 vs 10 in 2017-21 · Latest publication 2025
Audience (LinkedIn): 67k LinkedIn followers — 12.4% of this cohort's audience
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Mar 2026Series B$33M
- Jan 2023Grant (prize money)$216.4K
- Jun 2022Series B$80M
- Nov 2021Series B$180M
Founders & team
Investors
Eight Roads Ventures, F-Prime Capital, Google Ventures, MACSF, Cathay Innovation, Bpifrance
Tech stack
Amazon SesAmazon Web ServicesApple Icloud MailCdnjsCloudflareCloudflare Bot Management
#2
Public · Paris, Ile de France · founded 2012 · 32 employees$96.9Mraised▾
Public · Paris, Ile de France · founded 2012 · 32 employees
Provider of analytical services for microbiology, chemistry, and bioprocesses industries. It has developed its product known as Afynerie, technology, which directly valorizes non-food biomass (wastes) into biomolecules of high energetical and chemical interest. The company offers services including the measurement of methane volume (or more generally biogas) produced by degradation of organic substrates by anaerobic microorganisms, & organic substrates physicochemical characterization.
Fliar Intelligence Index™ 40how this company ranks against its industry peers
Funding
top 25%Talent
top 28%Moat
top 35%Patents
top 37%Tech
top 43%Innovation
top 48%Funding: Raised $96.9M across 7 rounds · 7 rounds over 11 yrs (0.6/yr) · Last round Grant (prize money) (Apr 2026)
Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 5/10 · IP moat: 118 patents · 9 curated direct competitors tracked
Audience (LinkedIn): 20k LinkedIn followers — 3.7% of this cohort's audience
Funding rounds
- Apr 2026Grant (prize money)$3.5M
- Feb 2026Post IPO$8.2M
- Nov 2025Post IPO$26.6M
- Jul 2025Grant (prize money)$4.7M
Founders & team
Investors
JEREMIE AUVERGNE, Valquest Capital Management, Sofinnova Partners, Bpifrance, Kemin, Odyssee Venture
Tech stack
Apache Http ServerComplianzContact Form 7Core-JsDropzoneFormidable Form
#3
Public · Paris, Ile de France · founded 2001 · 3 employees$83.2Mraised▾
Public · Paris, Ile de France · founded 2001 · 3 employees
Developer of tyrosine kinase inhibitors for multiple disease indications. The company's lead candidate drugs are masitinib, a highly selective tyrosine kinase inhibitor, and AB8939, a new generation microtubule destabilizer for oncology, neurodegenerative and inflammatory indications.
Fliar Intelligence Index™ 42how this company ranks against its industry peers
Funding
top 20%Patents
top 21%Innovation
top 28%Moat
top 28%News
top 33%Growth
top 45%Funding: Raised $83.2M across 9 rounds · 9 rounds over 9 yrs (1.0/yr) · Last round Post IPO (May 2026)
Patents: 461 patents matched (strict assignee match) · 78 filings since 2022 vs 86 in 2017-21 · Latest publication 2025
Innovation: 461 patents (top 5% of patent-holders) · 78 filings since 2022 vs 86 in 2017-21
Funding rounds
- May 2026Post IPO$3M
- Oct 2025Post IPO$3.3M
- Jul 2025Post IPO$2.3M
- May 2025Post IPO$2M
Tech stack
Contact Form 7Core-JsGoogle AnalyticsGoogle Font ApiGsapIsotope
#4
Public · Paris, Ile de France · founded 2011 · 23 employees$76.6Mraised▾
Public · Paris, Ile de France · founded 2011 · 23 employees
Developer of viral vector-based gene therapies for retinal neurodegenerative diseases. The company develops innovative approaches to prevent retinal degeneration in selected pathological conditions, to restore vision in patients suffering from very low vision or blindness. Its lead product candidates include GS010, an AAV2 containing the human wild-type ND4 gene for the treatment of Leber Hereditary Optic Neuropathy associated with a mutation in the ND4 gene, and GS030 which comprises a gene encoding a photoactivatable channelrhodopsin for the treatment of retinitis pigmentosa and geographic atrophy in dry age-related macular degeneration.
Fliar Intelligence Index™ 55how this company ranks against its industry peers
AI
top 15%Product
top 19%Funding
top 20%Patents
top 33%Moat
top 38%Innovation
top 43%AI: Holds AI/ML patents (G06N-family CPC)
Product: 3 distinct product lines · Company stage: Public
Funding: Raised $76.6M across 9 rounds · 9 rounds over 13 yrs (0.7/yr) · Last round Post IPO (Mar 2026)
Audience (LinkedIn): 10k LinkedIn followers
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Mar 2026Post IPO$2M
- Dec 2025Post IPO$3.4M
- Nov 2025Post IPO$2.3M
- Oct 2025Post IPO$4.3M
Investors
Abingworth, Versant Ventures, Index Ventures, Novartis Venture Fund, Fidelity Investments, Jennison
Tech stack
Apache Http ServerGoogle AnalyticsJqueryMediaelement.JsMicrosoft 365Microsoft Advertising
#5
Series A · Paris, Ile de France · founded 2017$165Mraised▾
Series A · Paris, Ile de France · founded 2017
Developer of novel medicines for mental health conditions. The company focuses on neuropsychiatric treatments rooted in clinically validated mechanisms. It advances programs for schizophrenia, psychotic disorders, major depressive disorder, and bipolar depression. The lead program is a dual agonist in Phase 1 development. Another program is a novel antagonist currently in IND-enabling studies.
Fliar Intelligence Index™ 22how this company ranks against its industry peers
Funding
top 20%Global
top 45%Talent
bottom 49%Tech
bottom 29%Market
bottom 25%Funding: Raised $165M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Series A (Dec 2025)
Global: Investors from 3 countries beyond France
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Audience (LinkedIn): 2k LinkedIn followers
Hiring (LinkedIn): 3 hiring posts in 12 mo (public) · momentum -2 · hiring: Chemistry Lead (R&D), CMCL Lead
Funding rounds
- Dec 2025Series A$165M
Founders & team
Investors
Dexcel, Third Rock Ventures, Bain Capital Life Sciences, Google Ventures, QVT Family Office, Pictet Group
Tech stack
Core-JsElementorGoogle Font ApiHello ElementorJqueryJquery Migrate
#6
Series B · Paris, Ile de France · founded 2017 · 12 employees$36.2Mraised▾
Series B · Paris, Ile de France · founded 2017 · 12 employees
Ablacare, now May Health provides a solution for restoring ovulation in patients with polycystic ovary syndrome. It gives a solution for an invasive treatment that is done transvaginally under ultrasound guidance without any anesthesia requirements.
Fliar Intelligence Index™ 40how this company ranks against its industry peers
Funding
top 29%Moat
top 29%Growth
top 35%Tech
top 47%News
top 48%Global
bottom 36%Funding: Raised $36.2M across 3 rounds · 3 rounds over 7 yrs (0.4/yr) · Last round Series B (Mar 2026)
Moat: Editorial + unicorn rating 7/10 · 1 curated direct competitors tracked
Growth: Fresh capital in last 24 mo
Audience (LinkedIn): 5k LinkedIn followers
Funding rounds
- Mar 2026Series B$11.7M
- May 2024Series B$25M
- Jul 2019Series A$11.2M
Investors
Sofinnova Partners, Trill impact, Bpifrance, Avestria Ventures, MD Start, Lifeblood Capital
Tech stack
Alpine.JsCivicthemeCloudflareCloudflare Bot ManagementCookieyesCore-Js
#7
Seed · Paris, Ile de France · founded 2019 · 10 employees$20.6Mraised▾
Seed · Paris, Ile de France · founded 2019 · 10 employees
Developer of robotic medical equipment for skin cancer detection. It offers autonomous robots equipped with third-dimension construction software that capture data by full-body mapping to detect skin cancer. It allow physicians to track the growth of moles on the body using off-the-shelf robots.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
AI
top 15%Patents
top 28%Innovation
top 32%Moat
top 32%Funding
top 38%Talent
bottom 49%AI: Holds AI/ML patents (G06N-family CPC)
Patents: 57 patents matched (strict assignee match) · 48 filings since 2022 vs 9 in 2017-21 · Latest publication 2026
Innovation: 57 patents (top 44% of patent-holders) · 48 filings since 2022 vs 9 in 2017-21 · Deep-tech classification: Tech Hardware
Funding rounds
- Apr 2026Seed$18M
- Jul 2022Grant (prize money)$2.6M
- 2022Grant (prize money)—
- Seed—
Founders & team
Investors
EIC Fund, Europa, Sonder Capital, Bpifrance, Adamed Technology, Teampact Ventures
Tech stack
Amazon Web ServicesHstsLenisNode.JsNuxt.JsOpen Graph
#8
Series C · Paris, Ile de France · founded 2015 · 16 employees$52Mraised▾
Series C · Paris, Ile de France · founded 2015 · 16 employees
Developer of a medical device for colorectal surgery. The company develops Colovac, a solution to reduce anastomotic complications and to obviate the need for diverting ostomies for patients undergoing colectomy. It uses a vacuum-based mechanism that is fully reversible. It remains in place until the body’s natural healing and tissue repair processes are complete, after which it is removed manually.
Fliar Intelligence Index™ 45how this company ranks against its industry peers
Funding
top 27%Growth
top 35%News
top 36%Tech
top 39%Moat
top 39%Patents
bottom 47%Funding: Raised $52.0M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) · Last round Series C (Sep 2025)
Growth: Fresh capital in last 24 mo
News: 3 BI events in 12 mo (of 6 tracked, 1 types) · +200% YoY · Top themes: Funding
Audience (LinkedIn): 2k LinkedIn followers
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Sep 2025Series C$11.7M
- Apr 2025Series C$39.9M
- Jan 2022Series B$44.6M
- Mar 2018Series A$7.4M
Investors
Sofinnova Partners, Genesis MedTech, MD Start, M&L Healthcare, Gideon Strategic Partners, Solar Eclipse
Tech stack
Animate.CssBootstrapCloudflareCloudflare Bot ManagementContact Form 7Cookieyes
#9
Series D · Paris, Ile de France · founded 2012 · 117 employees$67.1Mraised▾
Series D · Paris, Ile de France · founded 2012 · 117 employees
Provider of AI-powered exoskeleton solutions. It is a personal-use exoskeleton designed for everyday indoor and outdoor walking without crutches, currently undergoing clinical trials.
Fliar Intelligence Index™ 74how this company ranks against its industry peers
Innovation
top 19%Patents
top 22%Moat
top 26%Talent
top 28%Funding
top 31%Growth
top 35%Innovation: 132 patents (top 15% of patent-holders) · 78 filings since 2022 vs 41 in 2017-21 · Deep-tech classification: Tech Hardware
Patents: 132 patents matched (strict assignee match) · 78 filings since 2022 vs 41 in 2017-21 · Latest publication 2026
Moat: Editorial + unicorn rating 8/10 · IP moat: 132 patents · Soonicorn
Audience (LinkedIn): 28k LinkedIn followers — 5.3% of this cohort's audience
Activity (LinkedIn): 2 partnerships (incl. NSM) announced in 12 mo
Funding rounds
- Jun 2025Series D$75M
- Apr 2024Venture Debt$27.1M
- Jan 2022Series C$45M
- Jan 2018Grant (prize money)$675.6K
Founders & team
Investors
European Investment Bank, Idinvest Partners, Cemag Invest, Bpifrance, LBO France, XAnge
Tech stack
AxeptioCloudflareCloudflare Bot ManagementGoogle AnalyticsGoogle Font ApiGoogle Hosted Libraries
#10
Series B · Paris, Ile de France · founded 2014 · 44 employees$52.3Mraised▾
Series B · Paris, Ile de France · founded 2014 · 44 employees
Developer of in vivo gene editing technology for microbiome modulation. The company offers a platform to edit the microbiome's gene repertoire. This platform aims to address diseases triggered or aggravated by specific bacterial genes. The technology targets the interactions between the microbiome and the host's immune system.
Fliar Intelligence Index™ 48how this company ranks against its industry peers
Patents
top 16%Innovation
top 19%Moat
top 29%Funding
top 36%Tech
top 48%Talent
bottom 49%Patents: 199 patents matched (strict assignee match) · 142 filings since 2022 vs 57 in 2017-21 · Latest publication 2026
Innovation: 199 patents (top 13% of patent-holders) · 142 filings since 2022 vs 57 in 2017-21
Moat: Editorial + unicorn rating 7/10 · IP moat: 199 patents · 10 curated direct competitors tracked
Audience (LinkedIn): 16k LinkedIn followers — 2.9% of this cohort's audience
Hiring (LinkedIn): 3 hiring posts in 12 mo (public) · hiring: Research Scientist, Internship
Funding rounds
- May 2025Grant (prize money)$5M
- Nov 2023Series B$30.1M
- Mar 2022Grant (prize money)$55.7K
- Apr 2019Grant (prize money)$3.1M
Founders & team
Investors
Sanofi Ventures, Bpifrance, Khosla Ventures, Seventure Partners, EIC Fund, Europa
Tech stack
Amazon Web ServicesApple Icloud MailBootstrapChart.JsCloudflareCloudflare Browser Insights
#11
Series A · Paris, Ile de France · founded 2022 · 5 employees$8.6Mraised▾
Series A · Paris, Ile de France · founded 2022 · 5 employees
Developer of microbial detection technology for life science industries. The company is developing innovative technologies to detect bacterial and microbial risk for various industries food&beverage, cosmetics, and pharmaceutics manufacturers.
Fliar Intelligence Index™ 53how this company ranks against its industry peers
AI
top 15%Growth
top 35%Talent
top 38%Funding
top 42%Moat
top 42%Tech
top 43%AI: Holds AI/ML patents (G06N-family CPC)
Growth: Fresh capital in last 24 mo
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Audience (LinkedIn): 13k LinkedIn followers — 2.3% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Senior Computer Vision Data Scientist
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Jan 2026Grant (prize money)—
- Feb 2025Series A$23M
- Dec 2023Seed$8.6M
Founders & team
Investors
LocalGlobe, EmergingTech Ventures, No Label Ventures, Family C Venture, Better Angle, Singular
Tech stack
Animate.CssCloudflareFont AwesomeGoogle Font ApiGoogle Hosted LibrariesGoogle Workspace
#12
Series A · Paris, Ile de France · founded 2019 · 60 employees$62.7Mraised▾
Series A · Paris, Ile de France · founded 2019 · 60 employees
Provider of an AI and quantum physics to discover therapeutic molecules. The software uses AI-Based technology for screening different small molecules, knowing its physical properties helping in upstream processing and drug discovery. The software also helps in determining therapeutic targets responsible for particular diseases.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Funding
top 28%AI
top 30%Moat
top 38%Tech
top 39%Innovation
top 44%Growth
top 48%Funding: Raised $62.7M across 5 rounds · 5 rounds over 7 yrs (0.7/yr) · Last round Grant (prize money) (Apr 2025)
AI: Classified as an AI company · Product described with: ai-based
Moat: Editorial + unicorn rating 7/10 · IP moat: 4 patents
Audience (LinkedIn): 23k LinkedIn followers — 4.3% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Le Figaro article
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Apr 2025Grant (prize money)$7.4M
- Dec 2024Series A$40.1M
- Jan 2024Series A$32.5M
- Oct 2022Series A$29.1M
Founders & team
Investors
Elaia, Eurazeo, Bpifrance, Cathay Innovation, Wendel, Gouv.fr
Tech stack
Amazon SesAmazon Web ServicesApple Icloud MailGoogle AnalyticsGoogle Tag ManagerGoogle Workspace
Funding & investor landscape
$4.8Btotal disclosed funding
145companies funded
445disclosed rounds
3rounds last 90 days
Most active investors
Omnes Capital12 rounds
Notable founders
Gilles Wainrib
Co-Founder · Owkin
Thomas Clozel
Chief Executive Officer and Co-founder · Owkin
Regis Nouaille
Co-Founder · AFYREN
Nicolas Sordet
Founder & CEO · AFYREN
Elisabeth Kogan
Co-Founder & CEO · Syremis
Ali Khachlouf
Co-Founder & CEO · SquareMind
Alexandre Boulanger
Co-Founder · Wandercraft
Matthieu Masselin
Co-Founder & CEO · Wandercraft
Xavier Duportet
Co-Founder & CEO · Eligo Bioscience
Amine Raji
Co-Founder & CEO · Spore Biotechnologies
Maxime Mistretta
Co-founder & CTO · Spore Biotechnologies
Maximilien Levesque
Founder & CEO · Aqemia
Prism market signals · France · country-scoped Prism corpus, 2,021,151 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH IN PARIS · Health & Bio
How research on Biotechnology in Paris is moving
A read on the academic research around Biotechnology in Paris — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 143 papers.
AgroParisTech, Université Paris-Saclay, and Université Paris Cité lead Paris's biotechnology research, focusing predominantly on antibiotic resistance and mitochondrial function, with a cautiously optimistic tone.
143 papers · stance +0.39 · 32% breakthrough · 21% concern
top institutions
- AgroParisTech36
- Université Paris-Saclay33
- Université Paris Cité19
- Assistance Publique – Hôpitaux de Paris17
- CEA Paris-Saclay13
leading researchers
Carmela Gallo · Emiliano Manzo · Emma Cauzzi · Livia La Barbera · Lucia Verrillo · Audrey Tiercin
prism intelligence · tone & topics
88% positive · 6% critical tone
HealthMedical ResearchAgriculturePharmaceuticalsBiologyGenetics
▲
Breakthroughs35 · 24%
▲ 18%→25% share
▲1.4× share momentum0 median citations80% since 2021mostly empirical
Gene and Genome research is surging — field-share rose 18%→25% with 4 new papers each newly emerging.
rising sub-themes (early→recent)
- Gene4
- Genome4
- Cell culture3
- DNA damage3
- Mutation3
Newly emergingGene 0→4 · Genome 0→4 · Cell culture 0→3
Landmark High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplas · 654 cites
◆
Advancements52 · 36%
▼ 50%→36% share
▼0.7× share momentum0 median citations77% since 2021mostly empirical
Disease sub-topic tripled (1→3 papers) while Gene and Selection algorithms newly entered advancements at 5 and 3 papers.
rising sub-themes (early→recent)
- Disease1→3
Newly emergingGene 0→5 · Selection (genetic algorithm) 0→3 · Context (archaeology) 0→3
Landmark Quantum dots: bright and versatile in vitro and in vivo fluorescence imaging biosensors · 933 cites
▼
Concerns23 · 16%
▼ 23%→15% share
▼0.7× share momentum0 median citations74% since 2021mostly empirical
Antibiotic resistance and Interferon concerns are newly emerging at 3 papers each, intensifying despite overall concern share falling 23%→15%.
rising sub-themes (early→recent)
- Selection (genetic algorithm)3
- Antibiotic resistance3
- Interferon3
- Food science3
- Gene3
Newly emergingSelection (genetic algorithm) 0→3 · Antibiotic resistance 0→3 · Interferon 0→3
Landmark A standardised staticin vitrodigestion method suitable for food – an international consensus · 5,317 cites
Common questions
How many Life Sciences companies are there in Paris, France?
Radar tracks 300 indexable Life Sciences companies headquartered in Paris, France that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Paris, France?
The Life Sciences companies in Paris, France on this list have raised a combined $4.8B in disclosed equity funding across 145 funded companies.
Which is the highest-funded Life Sciences company in Paris, France?
Owkin is the highest-funded Life Sciences company in Paris, France, with $321.1M in disclosed equity funding.
How many Life Sciences companies in Paris, France are funded?
145 of the 300 Life Sciences companies in Paris, France on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Paris, France?
1 Life Sciences company in Paris, France on this list is valued at $1B or more.
Who are the top investors in Paris, France Life Sciences companies?
The most active investors in Paris, France Life Sciences companies on this list include Bpifrance, Europa, EIC Fund, Sofinnova Partners, EIT Health.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.